Navigation Links
Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome
Date:12/29/2011

l. For patients with CrCl 15 to 50 mL/min, the recommended dose is 15 mg once daily with the evening meal.
  • Prophylaxis of Deep Vein Thrombosis: The recommended dose of XARELTO® is 10 mg taken orally once daily with or without food. The initial dose should be taken at least 6 to 10 hours after surgery once hemostasis has been established.
    • For patients undergoing hip replacement surgery, treatment duration of 35 days is recommended.
    • For patients undergoing knee replacement surgery, treatment duration of 12 days is recommended.
  • Missed Dose: If a dose of XARELTO® is not taken at the scheduled time, administer the dose as soon as possible on the same day.
  • Instructions for Patient Use
    • Remind patients to not discontinue XARELTO® without first talking to their healthcare professional to minimize the risk of post-discontinuation thrombotic events.
    • Advise patients with atrial fibrillation to take XARELTO® once daily with the evening meal.
  • DRUG INTERACTIONS

    • Drugs That Inhibit CYP3A4 Enzymes and Drug Transport Systems: Avoid concomitant administration of XARELTO® with combined P-gp and strong CYP3A4 inhibitors (eg, ketoconazole, itraconazole, lopinavir/ritonavir, ritonavir, indinavir/ritonavir, and conivaptan), which cause significant increases in rivaroxaban exposure that may increase bleeding risk.
    • Drugs That Induce CYP3A4 Enzymes and Drug Transport Systems: Avoid concomitant use of XARELTO® with drugs that are combined P-gp and strong CYP3A4 inducers (eg, carbamazepine, phenytoin, rifampin, St. John's wort) due to decreases in rivaroxaban exposure that may decrease efficacy.
    • NSAIDs/Aspi
      '/>"/>

    SOURCE Janssen Research & Development, LLC
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Record Breaking $327 Million Verdict Upheld in Janssen Case and Request for New Trial Denied
    2. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
    3. Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc.
    4. Janssen Pharmaceuticals, Inc. Launches Online Tools on PrescribeResponsibly.com
    5. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
    6. Dr. Napoleone Ferrara Wins 2011 Dr. Paul Janssen Award for Biomedical Research
    7. Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease
    8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
    9. Record Breaking $327 Million Verdict Announced in Janssen Case
    10. MHPA Center for Best Practices Receives Sponsorship from Ortho-McNeil Janssen Pharmaceuticals, Inc. to Improve Medicaid Quality, Care Coordination for Serious Mental Illness
    11. Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... , July 23, 2014 Inovio ... successful results from its randomized, double-blind, placebo-controlled ... with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) ... or 18. Treatment with VGX-3100, Inovio,s HPV16/18-specific ... to CIN1 or no disease, meeting the ...
    (Date:7/23/2014)...  The management team at Columbia Laboratories, Inc. ... conference call on July 31, 2014, to discuss ... 30, 2014.  The call details are as follows:Date: ... EDTDial-in numbers: , Toll free: (877) 870-4263 (U.S.), ... archive): , www.columbialabs.com , under ,Investor, or ...
    (Date:7/23/2014)... Global healthcare company GSK reports ... headwinds, increased price competition and supply disruptions to its ... points out that the company is very much in ... be confident about long-term prospects as well as the ... CFO Simon Dingemans adds that the company ...
    Breaking Medicine Technology:Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2
    ... SPRING, Md., June 20, 2011 The U.S. Food ... help advance the development and approval of an artificial ... United States. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... condition in which the pancreas produces little or no ...
    ... (NYSE Amex: CUR ) announced that it has ... Phase Ia trial to test the safety of NSI-189 for ... drug in healthy volunteers for safety and tolerability. NSI-189 is ... new neuron growth in the hippocampus, an area of the ...
    Cached Medicine Technology:FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 2FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System 3Neuralstem Updates NSI-189 Major Depression Trial 2Neuralstem Updates NSI-189 Major Depression Trial 3
    (Date:7/23/2014)... combining salmon fibrin injections into the spinal cord and ... voluntary motor function impaired by spinal cord injury, scientists ... In a study on rodents, Gail Lewandowski and Oswald ... clock in a molecular pathway critical to the formation ... so that neuronal axons at the injury site could ...
    (Date:7/23/2014)... 2014 This report defines and segments ... Europe, the Middle East & Africa, and Americas) - ... geography with analysis and forecasts of the global revenue. ... from over $10 billion in 2014 to nearly $14 ... , browse 49 Market Tables and 10 Figures ...
    (Date:7/23/2014)... A Forever Recovery, an open-ended drug ... a great start and gives them a solid foundation ... new Internet Addiction section of its website at ... that Internet addiction is not just as legitimate a ... it’s trapping more and more victims each year – ...
    (Date:7/23/2014)... -- Children and teens who lose a parent might face ... new study suggests. People who were children or teens ... of death during the study period than those who had ... report. Although the study found an association between a ... it wasn,t designed to prove cause-and-effect. Also, the increased ...
    (Date:7/23/2014)... 2014 SafeUseNow? , a ... developed by Principled Strategies , today announced ... California . Utilizing SafeUseNow’s patent-pending risk model, Partnership ... misusing and abusing controlled substance drugs, particularly prescription ... its members. , The agreement with Partnership HealthPlan ...
    Breaking Medicine News(10 mins):Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4
    ... artists like Ram Kumar, V S Gaitonde and Jehangir ... of contemporary Indian paintings and sculptures held at Durban ... // ,Since having a cultural co-operation between Indian ... between the gallery like Iziko South African National Gallery ...
    ... painstaking and reaps benefits only when done with full dedication. ... in Georgetown. This has brought to the world the first cancer ... when on June 8, the Food and Drug Administration approved the ... of HPV. ,In the doctor’s own words, "It's a ...
    ... colleagues at the Indiana University Medical Center, Indianapolis say ... into having unwanted sex //. ,Unwanted sex ... researchers write in the June issue of the Archives ... result in risk for sexually transmitted infections and pregnancies. ...
    ... inputs on the manner of T-cells enabling immunity and furthering ... will go a long way in measuring the efficiency of ... ,Led by researchers at Beth Israel Deaconess Medical ... National Institute of Allergy and Infectious Diseases (NIAID), part of ...
    ... leader Sri Sri Ravishankar has said practising yoga, pranayam and ... alcohol abuse. // ,'Youths crave for something different ... dhyan (meditation) to them,' he said while interacting with reporters ... Kundaim, 15 km from here., ,Ravi Shankar appealed to ...
    ... that secondhand smoking can be deadly. Hence California and Washington laws ... was 58 years old physically fit suffered from heart problems that ... he worked in smoky taverns for 37 years. So the doctors ... to find that the indoor air pollution levels in bars that ...
    Cached Medicine News:Health News:Research on AIDS vaccine a wealth of information 2Health News:Research on AIDS vaccine a wealth of information 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: